One source of medication information
Psychiatric Genetic Testing in Miami
Pharmacogenetic testing may provide information about selected gene-drug relationships. At Renova Health, results are interpreted alongside symptoms, diagnosis, medical history, current and previous medications, treatment response, side effects, family history, and patient goals.
What pharmacogenetic testing can show
Some genetic variants affect how the body metabolizes particular medications or may be associated with a different risk of certain adverse effects. The FDA maintains tables of gene-drug associations and pharmacogenomic information found in approved drug labeling. When a relevant association is well established, the information may help a prescriber consider dosing, monitoring, or a medication choice.
What the test cannot determine
A psychiatric genetic test does not diagnose ADHD, anxiety, depression, bipolar disorder, or another mental-health condition. It cannot account for every reason a medication may or may not help, and it cannot guarantee effectiveness or freedom from side effects. Symptoms, co-occurring conditions, sleep, substances, adherence, dose, duration, interactions, medical factors, and personal circumstances still matter.
An easy-to-read commercial category such as green, yellow, or red should not be interpreted as a complete treatment recommendation. The FDA notes that inclusion of a gene-drug association in its table does not automatically mean testing is recommended before prescribing, unless an approved companion diagnostic is required.
When testing may be worth discussing
- Several medication trials produced difficult side effects or an unusual response.
- A medication with an established pharmacogenetic relationship is being considered.
- Multiple medications or medical conditions make the treatment review more complex.
- Prior testing exists and the patient wants help understanding what it does and does not mean.
How Renova Health uses the information
The process begins with a psychiatric evaluation and a careful medication history. If testing is likely to add useful information, the clinician discusses limitations, cost or insurance questions, the collection process, and how results will be interpreted. Testing is not ordered simply to replace clinical judgment.
Results are reviewed in the context of the full treatment plan. A medication categorized as potentially compatible may still be inappropriate for other reasons, while a medication associated with altered metabolism may sometimes remain usable with different dosing, monitoring, or another clinical strategy.
Questions patients often ask
Can genetic testing tell me which antidepressant will work?
No test can reliably guarantee which medication will be effective for an individual. Results may offer limited information about selected gene-drug relationships and must be combined with clinical evidence and the patient's history.
Does a result mean I should stop a medication?
No. Do not start, stop, or change medication based only on a report. Abrupt changes can cause withdrawal, relapse, or other harm. Review the result with the prescribing clinician.
Is testing required before psychiatric medication?
Usually not. Some drug labels include pharmacogenomic information, but the FDA states that a listed association does not necessarily mean a test is recommended before prescribing unless the test is a required companion diagnostic.
Will insurance pay for testing?
Coverage varies according to the test, diagnosis, plan, and medical-necessity criteria. The office can discuss verification, but coverage and patient responsibility must be confirmed for the individual plan.